ArticleEuropean journal of clinical pharmacology2022

Role of ADME gene polymorphisms on imatinib disposition: results from a population pharmacokinetic study in chronic myeloid leukaemia.

Bharati Shriyan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.